NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/25/2025
Back to search
Official data from USPTO
CUREPSP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000086602516Class
35, 36, 41, 42, 44, 45
Filing
86602516
Registration
4870060
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
07/15/2025
Trademark type
Combined
Nice classes
35, 36, 41, 42, 44, 45
Filing date
04/20/2015
Registration date
12/15/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2025
Last transaction
07/15/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/01/2006
First use in commerce
01/01/2006
Drawing code
5
Owner type
03
Owner location
New York, NY
Examiner
CASE, LEIGH
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized term "CUREPSP". The letters "CURE" are in large lower-case stylized font and the letters "PSP" are in bold upper-case stylized font.
Holders and representatives
Holders
CUREPSP, INC.
Foundation for PSP | CBD and Related Brain Diseases, Inc.
Representatives
Alberto Zacapa DLA PIPER LLP (US)
Technical classification
Nice Classes
Class 35Class 36Class 41Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting public interest and awareness of neurological disorders; administration and management of research grants; business consulting and management in the field of clinical trialsproviding information management services; business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; recruitment advertisement servicesposting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; franchisingoffering business management assistance in the establishment and/or operation of non-profit organizations in the field of neurological disorders and research centers in the field of brain disease and disorders
Class 36
Charitable fund raising; charitable fund raising services for funding medical research programspatient services programsclinical centersrelated programs and activities; financial sponsorship of medical researchtreatment and preventative initiatives
Class 41
Arranging and conducting educational conferences; educational servicesproviding non-downloadable webinars in the field of neurological disorders; providing educational servicesclasses and course materials in connection therewith to healthcare professionals and the general public in the field of neurological disorders
Class 42
Medical and scientific research in the field of brain disease and disorders; conducting clinical trials for others in the field of neurological disorders; providing a website featuring information on scientific research in the field of neurological disorders
Class 44
Providing information in the field of health care; providing information in the field of organ and tissue donation; providing a website featuring information on neurological disorders and treatment in the field of neurological disorders
Class 45
Providing personal support services for patients and families of patientsemotional counseling and emotional support
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/25/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/25/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/25/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
01/16/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/15/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/19/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/19/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/19/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/19/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/19/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/18/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/18/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/18/2022
E815
TEAS SECTION 8 & 15 RECEIVED
01/10/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/15/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/23/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
12/15/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/29/2015
PUBO
PUBLISHED FOR OPPOSITION
09/29/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/09/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/25/2015
ALIE
ASSIGNED TO LIE
08/24/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/06/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
08/03/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/03/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
08/03/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/03/2015
DOCK
ASSIGNED TO EXAMINER
07/29/2015
MPMK
NOTICE OF PSEUDO MARK E-MAILED
04/29/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/28/2015
NWAP
NEW APPLICATION ENTERED
04/23/2015
Continuous trademark protection
Get notified about every new filing that threatens CUREPSP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.